CIK 0001541157 · Non-accelerated filer<br>Smaller reporting company
Akari Therapeutics Plc
Sign in to watch- Ticker
- AKTX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- United Kingdom
- Entity type
- operating
- EIN
- 981034922
- Phone
- (929) 274-7510
- Business address
- 401 EAST JACKSON STREET, SUITE 3300, TAMPA, FL, 33602
- Former names
- Celsus Therapeutics Plc., Morria Biopharmaceuticals PLC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-10-14 | Patel Sandip I Director | Option exercise | +3,866 | $0.00 | $2 | 32,691 |
| 2026-10-14 | Patel Sandip I Director | Option exercise | +6,186 | $0.00 | $2 | 38,877 |
| 2026-10-14 | Patel Sandip I Director | Option exercise · Pre-Funded Warrant to Purchase ADSs | −3,866 | $16.16 | $62K | 0 |
| 2026-10-14 | Patel Sandip I Director | Option exercise · Pre-Funded Warrant to Purchase ADSs | −6,186 | $16.16 | $100K | 0 |
| 2026-10-14 | Bazemore Robert B Director | Option exercise | +773 | $0.00 | $0 | 19,666 |
| 2026-10-14 | Bazemore Robert B Director | Option exercise | +3,093 | $0.00 | $1 | 22,759 |
| 2026-10-14 | Bazemore Robert B Director | Option exercise · Pre-Funded Warrant to Purchase ADSs | −773 | $16.16 | $12K | 0 |
| 2026-10-14 | Bazemore Robert B Director | Option exercise · Pre-Funded Warrant to Purchase ADSs | −3,093 | $16.16 | $50K | 0 |
| 2026-10-14 | Gaslightwala Abizer CEO | Option exercise | +19,333 | $0.00 | $8 | 33,440 |
| 2026-10-14 | Gaslightwala Abizer CEO | Option exercise | +7,733 | $0.00 | $3 | 41,173 |
| 2026-10-14 | Gaslightwala Abizer CEO | Option exercise · Pre-Funded Warrant to Purchase ADSs | −19,333 | $16.16 | $312K | 0 |
| 2026-10-14 | Gaslightwala Abizer CEO | Option exercise · Pre-Funded Warrant to Purchase ADSs | −7,733 | $16.16 | $125K | 0 |
| 2026-10-12 | Vat-Ho Vatnak Chief Business Officer | Grant or award · Stock Option (Right to Buy) | +87,000 | 87,000 | ||
| 2026-10-05 | Prudo-Chlebosz Raymond Director | Grant or award | +3,240 | $7.90 | $26K | 76,861 |
| 2026-10-05 | Huh Hoyoung Director | Grant or award | +6,160 | $7.90 | $49K | 140,805 |
| 2026-10-05 | Patel Sandip I Director | Grant or award | +4,313 | $7.90 | $34K | 28,825 |
| 2026-10-05 | Bazemore Robert B Director | Grant or award | +4,677 | $7.90 | $37K | 18,893 |
| 2026-10-05 | Patel Samir Rashmikant Director | Grant or award | +2,236 | $7.90 | $18K | 12,102 |
| 2026-09-29 | Gaslightwala Abizer CEO | Grant or award | +6,430 | $9.72 | $62K | 14,107 |
| 2026-08-18 | Prudo-Chlebosz Raymond Director | Grant or award | +9,072 | $7.90 | $72K | 73,621 |
Page 1 of 11 · 216 trades